Andrew D. Dickinson
Chief Financial Officer at Gilead Sciences · 27 reported transactions in 1 company · latest trade Sep 15, 2026
Their trades
Sold | Sep 15, 2026 | Sep 15, 2026 close $146.30 → Oct 29, 2026 close $165.61. S&P 500 +1.6% over the same days. | ||
Sold | Aug 17, 2026 | Aug 17, 2026 close $138.92 → Oct 29, 2026 close $165.61. S&P 500 −0.4% over the same days. | ||
Sold | Jul 15, 2026 | Jul 15, 2026 close $131.70 → Oct 29, 2026 close $165.61. S&P 500 +1.9% over the same days. | ||
Sold | Jun 15, 2026 | Jun 16, 2026 close $127.23 → Oct 29, 2026 close $165.61. S&P 500 +2.5% over the same days. | ||
Sold | May 15, 2026 | May 15, 2026 close $129.58 → Oct 29, 2026 close $165.61. S&P 500 +4.1% over the same days. |
SoldGilead Sciences
$435.9K
Sep 15, 2026 close $146.30 → Oct 29, 2026 close $165.61. S&P 500 +1.6% over the same days.
SoldGilead Sciences
$415.1K
Aug 17, 2026 close $138.92 → Oct 29, 2026 close $165.61. S&P 500 −0.4% over the same days.
SoldGilead Sciences
$389.8K
Jul 15, 2026 close $131.70 → Oct 29, 2026 close $165.61. S&P 500 +1.9% over the same days.
SoldGilead Sciences
$376.2K
Jun 16, 2026 close $127.23 → Oct 29, 2026 close $165.61. S&P 500 +2.5% over the same days.
SoldGilead Sciences
$396.8K
May 15, 2026 close $129.58 → Oct 29, 2026 close $165.61. S&P 500 +4.1% over the same days.